Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

Author： Plaxe S.C.   Blessing J.A.   Bookman M.A.   Creasman W.T.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.1, 2002-01, pp. : 32-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of CI-958 in Recurrent Platinum-Sensitive Ovarian Carcinoma: A Gynecologic Oncology Group Study

By Hoffman M.A.   Blessing J.A.   Nunez E.R.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 433-435

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Markman M.   Blessing J.A.   Alvarez R.D.   Hanjani P.   Waggoner S.   Hall K.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 112-115

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Plaxe S.C.   Blessing J.A.   Husseinzadeh N.   Webster K.D.   Rader J.S.   Dunton C.J.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite

Phase II Trial of CI-958 in Recurrent Platinum-Refractory Ovarian Carcinoma - A Gynecologic Oncology Group Study

By Hoffman M.A.   Blessing J.A.   Morgan M.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 463-465

Elsevier

Access to resources Recommend Favorite

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

By Manetta A.   Blessing J.A.   Hurteau J.A.  

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 45-46

Elsevier

Access to resources Recommend Favorite